Synapse

← Harlan M. Krumholz

Papers by Harlan M. Krumholz

Page 8 · newest first

  1. Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized TreatmentCirculation Cardiovascular Quality and Outcomes · 2021
  2. Change in Symptoms and Immune Response in People with Post-Acute Sequelae of SARS-Cov-2 Infection ( PASC ) After SARS-Cov-2 Vaccination2021
  3. Neural Natural Language Processing for Unstructured Data in Electronic Health Records: a Review2021
  4. Characterizing Dual Combination Therapy Use in Treatment Escalation of Hypertension: Real-World Evidence from Multinational Cohorts2021
  5. Multicentre methodological study to create a publicly available score of hospital financial standing in the USABMJ Open · 2021
  6. Trends and geographical variation in population thriving, struggling and suffering across the USA, 2008–2017: a retrospective repeated cross-sectional studyBMJ Open · 2021
  7. National Trends and Disparities in Hospitalization for Hypertensive Emergencies Among Medicare Beneficiaries, 1999–20192021
  8. Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018Circulation Cardiovascular Quality and Outcomes · 2021
  9. Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United StatesJACC CardioOncology · 2021
  10. Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient BoostingCirculation Cardiovascular Quality and Outcomes · 2021
  11. Mortality From Drug Overdoses, Homicides, Unintentional Injuries, Motor Vehicle Crashes, and Suicides During the Pandemic, March-August 2020JAMA · 2021
  12. Out‐of‐Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United StatesJournal of the American Heart Association · 2021
  13. Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes MellitusJournal of the American Heart Association · 2021
  14. Incorporating Present-on-Admission Indicators in Medicare Claims to Inform Hospital Quality Measure Risk Adjustment ModelsJAMA Network Open · 2021
  15. Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials2021
  16. The association of neighborhood walkability with health outcomes in older adults after acute myocardial infarction: The SILVER-AMI studyPreventive Medicine Reports · 2021
  17. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized TrialThrombosis and Haemostasis · 2021
  18. Effectiveness of An Impedance Cardiography Guided Treatment Strategy to Improve Blood Pressure Control in A Real-World Setting: Results from A Pilot Pragmatic Clinical Trial2021
  19. Implementing Measurement Science for Electronic Health Record UseJAMA · 2021
  20. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infectionPLoS ONE · 2021
  21. Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive PatientsHypertension · 2021
  22. Hemodynamic Differences Between Women and Men with Elevated Blood Pressure in China: A Non-Invasive Assessment of 45,082 Adults Using Impedance Cardiography2021
  23. Leveraging Open Science to Accelerate ResearchNew England Journal of Medicine · 2021
  24. Prevalence of Missing Data in the National Cancer Database and Association With Overall SurvivalJAMA Network Open · 2021
  25. Accuracy of Computable Phenotyping Approaches for SARS-CoV-2 Infection and COVID-19 Hospitalizations from the Electronic Health Record2021
  26. Assessment of Concordance and Discordance Among Clinical Studies Posted as Preprints and Subsequently Published in High-Impact JournalsJAMA Network Open · 2021
  27. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care UnitJAMA · 2021
  28. Rationale and design of the Learning Implementation of Guideline-based decision support system for Hypertension Treatment (LIGHT) Trial and LIGHT-ACD Trial2021
  29. Use of Machine Learning Models to Predict Death After Acute Myocardial InfarctionJAMA Cardiology · 2021
  30. Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial InfarctionCirculation Cardiovascular Quality and Outcomes · 2021
  31. Clinical Decision Support in Cardiovascular Medicine: Effectiveness, Implementation Barriers, and Regulation2021
  32. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19Nature Communications · 2021
  33. Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19Journal of the American Heart Association · 2021
  34. Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic ShockJAMA Network Open · 2021
  35. SARS-CoV-2 Infection Hospitalization Rate and Infection Fatality Rate Among the Non-Congregate Population in ConnecticutThe American Journal of Medicine · 2021
  36. Temporal relationship of computed and structured diagnoses in electronic health record dataBMC Medical Informatics and Decision Making · 2021
  37. Administrative Claims Measure for Profiling Hospital Performance Based on 90-Day All-Cause Mortality Following Coronary Artery Bypass Graft SurgeryCirculation Cardiovascular Quality and Outcomes · 2021
  38. Association of Graduate Medical Education With Hospital Performance and Patient OutcomesJAMA Network Open · 2021
  39. Suicide Deaths During the COVID-19 Stay-at-Home Advisory in Massachusetts, March to May 2020JAMA Network Open · 2021
  40. Using Adversarial Images to Assess the Stability of Deep Learning Models Trained on Diagnostic Images in Oncology2021
  41. Impact of ST‐Segment–Elevation Myocardial Infarction Regionalization Programs on the Treatment and Outcomes of Patients Diagnosed With Non–ST‐Segment–Elevation Myocardial InfarctionJournal of the American Heart Association · 2021
  42. Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials2021
  43. 180-day readmission risk model for older adults with acute myocardial infarction: the SILVER-AMI studyOpen Heart · 2021
  44. A Survey of Challenges and Opportunities in Sensing and Analytics for Risk Factors of Cardiovascular DisordersACM Transactions on Computing for Healthcare · 2020
  45. Can Technology Solve Suboptimal Preventive CareJournal watch · 2020
  46. Engagement With COVID-19 Public Health Measures in the United States: A Cross-sectional Social Media Analysis from June to November 2020 (Preprint)2020
  47. Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysisThe Lancet Digital Health · 2020
  48. All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020JAMA · 2020
  49. Association Between Depressive Symptoms and Incident Cardiovascular DiseasesJAMA · 2020
  50. Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in ChinaJAMA Network Open · 2020